Aytu BioScience Announces Acceleration of U.S. Availability of COVID-19 IgG/IgM Rapid Test Based on Updated FDA Policy
Updated FDA Policy Likely Enables Near-Term Availability of COVID-19 Test in the U.S. ENGLEWOOD, CO / ACCESSWIRE / March 17, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU),